Genetic Technologies
Personalizing Health

search

  • Home
  • Corporate
  • Medical
    • Overview
    • Breast & Ovarian Cancer
    • Bowel & Uterine Cancer
    • Neurogenetics
    • Epilepsy
  • Forensics
    • Overview
    • Presumptive & Confirmatory Testing
    • Individual DNA Profiling
    • Species Identification
    • Animal Forensic Testing
  • Paternity
    • Legal - Paternity
    • Non Legal - Paternity
    • Legal Practitioners
    • Antenatal
    • Deceased Estate
    • DNA In A Day
    • Sibship
    • Twins
    • Y – Chromosome
    • DNA Profiling
    • Grandparent
    • Immigration
  • Personal
    • Overview
    • Sports Performance
    • Ancestry
  • Animals
    • DNA Testing
    • BITSA
    • Animal Forensics
  • Plants
    • Genomic Services
    • Xpress Sequencing
Announcements


BREVAGen data presented at ASCO 2010
BREVAGen data presented at ASCO 2010
 
Patent claims upheld in full by USPTO
Patent claims upheld in full by USPTO
 
EraGen Biosciences License
EraGen Biosciences license
 
Gen-Probe License
Gen-Probe License
 
Acquisition of BREVAGen
Acquisition of BREVAGen
 
Previous Announcements
  • Private placement of shares and ASX Appendix 3B
  • GTG Investor Update - March 2010
  • NASDAQ press release - 16 March 2010 Marketplace Rule 5810(b)
  • Expiry of options - 2 March 2010
<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>

Page 17 of 30
© Genetic Technologies Group 2009 11/09 GTG 08 2371
skynews

Announcements

  • Settlement with GeneSeek
  • Appendix 3B - 20 April 2012
  • Forfeiture of options - 19 April 2012

Latest News

  • GENE: 1H12 Earnings Preview
  • GTG Oct-Dec 2011 4C Commentary
  • Biotech Daily - The Year in Review - CEO Of The Year Dr Paul MacLeman


Share Price

asx_logo_horiz

Share Price: Genetic Technologies